General MedicationsORALStandard
MACRODANTIN
NITROFURANTOIN, MACROCRYSTALLINE
Standard Dose
25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MACRODANTIN is listed in Drugs@FDA under application 016620 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NITROFURANTOIN, MACROCRYSTALLINE Form and strength CAPSULE;ORAL - 25MG Sponsor ALMATICA Submission history Latest submission status date: 2021-01-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview MACRODANTIN is listed in Drugs@FDA under application 016620 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NITROFURANTOIN, MACROCRYSTALLINE Form and strength CAPSULE;ORAL - 25MG Sponsor ALMATICA Submission history Latest submission status date: 2021-01-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.